Study: AZ, Novartis cancer meds carry heart risks; FDA issues public comment rules;

@FiercePharma: Drugmakers settle healthcare fraud claims‎ for $421M. News | Follow @FiercePharma

> Pfizer's breast-cancer drug Aromasin and similar treatments from AstraZeneca and Novartis make women 26 percent more likely to develop heart disease than an older therapy, a study found. Report

> FDA has set up new rules for people who want to comment during its advisory panel meetings; the guidance outlines how people should request a time to talk and how FDA should respond. FDA release

> Bristol-Myers Squibb's (BMY) cancer drug Sprycel has been given marketing approval in Europe for the treatment of so-called Philadelphia chromosome positive chronic phase chronic myeloid leukemia, or CML. Item

> Abbott Laboratories CEO Miles White was appointed to the board of directors at Caterpillar. Report

> Strike action at AstraZeneca in the U.K. is still suspended in the long-running dispute over pensions. Article

> AstraZeneca has launched an iPhone app to provide UK healthcare professionals with information on genetic tests for lung cancer. Article

> Bayer is aiming to more than double sales in China by 2015 to about €5 billion, or $6.7 billion, with a major chunk of that growth resulting from a €1 billion expansion of polycarbonate production capacity. Story

> Hundreds of people who are to lose their jobs at a pharmaceutical company in Cornwall are to be offered a package of measures to help them find new work. Item

Biotech News

 @FierceBiotech: J&J offers $2.3B in bid for Crucell shares. Article | Follow @FierceBiotech

 @JohnCFierce: Enter the bio-dragon. China taps biotech as one of 7 industries that will grow at 20%+ rate for the next 10 years. News | Follow @JohnCFierce

> WSJ: Big investors pushing Charles River ($CRL) toward the auction block. Item

> Roche spotlights top late-stage drug prospects in pipeline review. Article 

> Teva's oral MS drug clears a PhIII hurdle. News

> NIH to create major new center to speed drug development. Item 

Vaccine News

> Fauci outlines R&D challenges to universal flu vaccine. Article

> PATH $100M meningitis vaccine costs only 50 cents a jab. News

> Bavarian Nordic gets good news on Prostvac. Story

Manufacturing News

> Abbott among top supply chain innovators of all time. Article

> Europe seeks drugs for track/trace trial. Report

> Putin expects big pharma presence in Russia. Item

> Hyderabad Airport joins cold chain age. Report

> Imported death penalty drug to be tested by FDA. News

And Finally... The U.S. Securities and Exchange Commission charged a Maryland business consultant and his uncle with insider trading in Sequenom stock, saying they used codes from the 1987 movie Wall Street to try to hide their scheme. Report